Welcome to our LinkedIn page! At the forefront of ophthalmic innovation, we are a distinguished network of ophthalmologists led by Dr. David Almeida, dedicated to advancing the future of eye care. Our mission is to accelerate pharmaceutical development and ophthalmic device innovation, translating groundbreaking ideas into market-ready solutions with unmatched speed and precision.
Our global presence is supported by a robust site network and state-of-the-art lab facilities, enabling us to harness decentralized data for superior research and training outcomes. Through Case X Academy, we offer hands-on training courses in multiple languages, reflecting our commitment to global excellence. We provide expert consulting, trial development, and swift market entry for ophthalmology drugs and products. Our agile approach ensures cost-efficiency while enhancing results and patient outcomes. With a focus on diversity, community, and patient safety, we drive forward-thinking solutions in ophthalmology. Join us in shaping the future of eye care and pharmaceutical advancement.
Company Details
- Founded
- -
- Address
- 2005 W 8th St, Erie,pennsylvania 16505,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.caseXglobal.com
- Keywords
- ophthalmology and retina.
- HQ
- Erie, Pennsylvania
Casexglobal Questions
Casexglobal's website is http://www.caseXglobal.com
Casexglobal's LinkedIn profile is https://www.linkedin.com/company/casexglobal
Casexglobal's industry is
Biotechnology Research
Casexglobal's top competitors are
Craniofacial Research And Study Center,
Clinical Ai,
Nicox,
Ocular Therapeutix, Inc.,
Erie Retina Research,
Nova Eye Medical,
Uneedle,
Ora,
Beyeonics™ Vision,
Ior Partners.
Casexglobal's categories are Biotechnology Research
Casexglobal's founding year is 2023
